Literature DB >> 26677884

Value of the intrarenal arterial resistivity indices and different renal biomarkers for early identification of diabetic nephropathy in type 1 diabetic patients.

Soha Abd El Dayem, Abo El Magd El Bohy, Amal El Shehaby.   

Abstract

BACKGROUND: The aim of this study was to compare resistivity index (RI) in type 1 diabetic patients and normal controls and to evaluate whether high RI is associated with different biomarkers of diabetic nephropathy (DN) as early detection of DN offers the best chance of delaying or possibly preventing progression to end-stage renal disease.
METHODS: The study included 62 type 1 diabetic patients and 30 healthy volunteers of the same age and sex. Blood samples were taken for assessment of glycosylated hemoglobin, lipid profile and urine samples were taken for assessment of albumin/creatinine ratio, neutrophil gelatinase-associated lipocalin (NGAL), liver-type fatty acid binding protein (L-FABP) and kidney injury molecule-1 (Kim-1). Forty-five diabetic patients and 30 controls had a renal Doppler ultrasonography. t-Test or Mann Whitney U-test for independent variables, Pearson's or Spearman correlation analysis were used.
RESULTS: The mean age of diabetic patients was 16.3±1.5 years, and mean duration of diabetes was 9.4±2.9 years. RI, albumin/creatinine ratio, NGAL, Kim-1 and L-FABP were significantly higher in diabetics than in controls. RI, NGAL, Kim-1, and L-FABP were significantly higher in microalbuminuric compared to normoalbuminuric diabetics. In normoalbuminuric diabetics, RI, NGAL, Kim-1 and L-FABP were significantly higher compared to controls. The study revealed significant positive correlation between the RI in diabetics and both KIM-1 and albumin/creatinine ratio.
CONCLUSIONS: Increased RI and renal biomarkers in diabetics are early sensitive specific markers of DN, even preceded the development of microalbuminuria, denoting that they can be used as an early and sensitive markers for early detection of DN.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26677884     DOI: 10.1515/jpem-2014-0397

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  10 in total

1.  The ZDSD rat: a novel model of diabetic nephropathy.

Authors:  Richard G Peterson; Charles Van Jackson; Karen M Zimmerman
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

2.  Usefulness of Doppler ultrasound for the early diagnosis of diabetic nephropathy in type 1 diabetes mellitus.

Authors:  Azar Nickavar; Baranak Safaeian; Hossein Zaeri; Mohammad Hadi Gharib; Tahereh Chaharnaei
Journal:  J Ultrasound       Date:  2021-02-20

3.  Follow Up of Value of the Intrarenal Resistivity Indices and Different Renal Biomarkers for Early Identification of Diabetic Nephropathy in Type 1 Diabetic Patients.

Authors:  Soha Abd El Dayem; Abo El Magd El Bohy; Mona Hamed; Solaf Ahmed
Journal:  Open Access Maced J Med Sci       Date:  2017-03-20

4.  Early Diagnosis of Kidney Damage Associated with Tobacco Use: Preventive Application.

Authors:  Javier Tascón; Marta Prieto; Alfredo G Casanova; Francisco J Sanz; Miguel A Hernández Mezquita; Miguel Barrueco Ferrero; Manuel A Gomez-Marcos; Luis Garcia-Ortiz; Laura Vicente-Vicente; Ana I Morales
Journal:  J Pers Med       Date:  2022-06-24

5.  Performance of urinary liver-type fatty acid-binding protein in diabetic nephropathy: A meta-analysis.

Authors:  Li Zhang; Shuai Xue; Meiyan Wu; Dan Dong
Journal:  Front Med (Lausanne)       Date:  2022-09-02

Review 6.  Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment.

Authors:  Nur Samsu
Journal:  Biomed Res Int       Date:  2021-07-08       Impact factor: 3.411

Review 7.  Urinary Markers of Tubular Injury in Early Diabetic Nephropathy.

Authors:  Temesgen Fiseha; Zemenu Tamir
Journal:  Int J Nephrol       Date:  2016-05-16

8.  Serum kidney injury molecule 1 and β2-microglobulin perform as well as larger biomarker panels for prediction of rapid decline in renal function in type 2 diabetes.

Authors:  Marco Colombo; Helen C Looker; Bassam Farran; Sibylle Hess; Leif Groop; Colin N A Palmer; Mary Julia Brosnan; R Neil Dalton; Max Wong; Charles Turner; Emma Ahlqvist; David Dunger; Felix Agakov; Paul Durrington; Shona Livingstone; John Betteridge; Paul M McKeigue; Helen M Colhoun
Journal:  Diabetologia       Date:  2018-10-05       Impact factor: 10.122

9.  Osteopontin for Early Detection of Microvascular and Macrovascular Type 1 Diabetic Complication.

Authors:  Soha M Abd El Dayem; Abo El Magd El Bohy; Ahmed A Battah; Mona Hamed; Shereen Hamdy Abd El Aziz
Journal:  Open Access Maced J Med Sci       Date:  2019-11-13

10.  Nitric Oxide Gene Polymorphism is a Risk Factor for Diabetic Nephropathy and Atherosclerosis in Type 1 Diabetic Patients.

Authors:  Soha M Abd El Dayem; Ahmed A Battah; Abo El Maged El Bohy; Solaf Ahmed; Mona Hamed; Safa Nabil Abd El Fattah
Journal:  Open Access Maced J Med Sci       Date:  2019-10-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.